PDUFA VI: BIO Survey Finds FDA Communication Problems
Executive Summary
Data may help industry stake out its negotiating position as formal talks near for user fee reauthorization.
You may also be interested in...
IND Sponsors Should Not Contact FDA Reviewers Directly, Draft Guidance Asserts
Industry has pressed for more latitude on communications with agency, but FDA emphasizes that review division regulatory project managers should be primary contact.
PDUFA Negotiations Begin With FDA Seeking Review System Reform
During the inaugural negotiating session for renewal of PDUFA, which covers OTC switch and other nonprescription product NDAs, FDA says among its goals are “enhancements to the review processes.” The five-hour session included the ground rules for the talks and FDA and industry representatives also laid out their general wants and needs.
PDUFA Negotiations Begin With FDA Seeking Review System Reform
During the inaugural negotiating session for renewal of PDUFA, which covers OTC switch and other nonprescription product NDAs, FDA says among its goals are “enhancements to the review processes.” The five-hour session included the ground rules for the talks and FDA and industry representatives also laid out their general wants and needs.